Disease Prevalence by Location
I cannot provide a specific disease prevalence estimate without knowing which location and which disease you are asking about. The question "[LOCATION]'s disease prevalence" requires you to specify both the geographic location and the disease of interest to receive an accurate, evidence-based answer.
Framework for Understanding Disease Prevalence Data
To provide you with useful prevalence information, I need clarification on:
Geographic Specification Required
- Country level (e.g., United States, Italy, Senegal) 1, 2, 3
- Regional level (e.g., Europe, Asia-Pacific, Sub-Saharan Africa) 1
- State/province level (e.g., Arizona, Missouri, Veneto region) 1, 2
- Urban vs. rural distinction, as prevalence often varies significantly between these settings 4
Disease Specification Required
- Infectious diseases such as spotted fever rickettsiosis (8.9 cases per million in the United States overall, but 63% concentrated in five states: Arkansas, Missouri, North Carolina, Oklahoma, and Tennessee) 1
- Chronic diseases including diabetes (prevalence 12.6% in Hispanic Americans, 11.8% in African Americans, 7.0% in European Americans) 1
- Cardiovascular conditions such as peripheral arterial disease (global prevalence 1.52%, increasing to 14.91% in those aged 80-84 years) 1
- Respiratory diseases including interstitial lung disease (72.1 to 164.2 cases per 100,000 Europeans) 5
- Rare diseases (cumulative point prevalence of 3.5-5.9% globally, affecting 263-446 million persons) 6
Key Methodological Considerations
Data Source Variations
- Administrative databases typically yield lower prevalence estimates than general practice records for conditions like diabetes (4.8-7.1% vs. 6.2-8.5%) 2
- Survey data may capture different populations than claims-based estimates, particularly for conditions like COPD 2
- Geographic trends remain consistent across data sources despite absolute prevalence differences 2
Population-Specific Factors
- Age stratification is critical, as prevalence increases dramatically with age for most chronic conditions (e.g., PAD prevalence 1.52% overall but 14.91% in 80-84 year-olds) 1
- Sex differences exist for many conditions, with females having higher prevalence of certain diseases (e.g., PAD: 18.03% vs. 10.56% in males aged 80-84) 1
- Race and ethnicity significantly impact prevalence (e.g., MS prevalence: 374.8 per 100,000 in White individuals, 298.4 in Black individuals, 161.2 in Hispanic individuals) 7
Please specify the location and disease you are interested in, and I will provide detailed, evidence-based prevalence data with appropriate citations and clinical context.